Suzanne Conzen to Chemotherapy, Adjuvant
This is a "connection" page, showing publications Suzanne Conzen has written about Chemotherapy, Adjuvant.
Connection Strength
0.136
-
Activation of the glucocorticoid receptor is associated with poor prognosis in estrogen receptor-negative breast cancer. Cancer Res. 2011 Oct 15; 71(20):6360-70.
Score: 0.078
-
Racial disparities in omission of oncotype DX but no racial disparities in chemotherapy receipt following completed oncotype DX test results. Breast Cancer Res Treat. 2018 Feb; 168(1):207-220.
Score: 0.030
-
High glucocorticoid receptor expression predicts short progression-free survival in ovarian cancer. Gynecol Oncol. 2017 07; 146(1):153-160.
Score: 0.029